Vaginal Microbiome-host Interaction in Mesh Exposure After TVM Surgery
Study Details
Study Description
Brief Summary
Transvaginal pelvic mesh implantation（TVM） is a foreign body implantation operation with intraoperative colonization of vaginal bacteria. However, the vaginal microbiome-host interaction and its influence in the mechanism of mesh exposure after TVM remains unclear. This study will enroll post-TVM patients with and without mesh exposure and use their vaginal swabs to perform TRACE-seq and cytokine analysis. The microbiome-host interactions related with mesh exposure and the changes in protein expression will be analyzed.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Patients with mesh exposure During the physical examination, a speculum was inserted into the vagina to observe the vaginal epithelium for mesh exposure. If the mesh is seen on surface of the vaginal mucosa, the patient is diagnosed with mesh exposure. |
|
| Patients without mesh exposure During the physical examination, a speculum was inserted into the vagina to observe the vaginal epithelium for mesh exposure. If the mesh is not seen on surface of the vaginal mucosa, bimanual examination will be performed to confirm no foreign body can be feeled on surface of the vaginal mucosa. Then the patient belong to this group. |
Outcome Measures
Primary Outcome Measures
- Vaginal microbiome-host interaction in patients after TVM [Over 6 months postoperative]
- Vaginal microbiome-host Interaction associated with mesh exposure after TVM [Over 6 months postoperative]
Secondary Outcome Measures
- Difference of vaginal microbiome between groups [Over 6 months postoperative]
- Differentially expressed genes in host-mesh interaction between groups [Over 6 months postoperative]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients with "III-IV degree uterine/apex/anterior vaginal wall prolapse and I-II degree of posterior vaginal wall prolapse" who agree to be treated by transvaginal pelvic mesh implantation.
-
All surgeries were performed by surgeons with extensive experience in transvaginal mesh implantation (>20 vaginal mesh implantation per year) using macroporous, monofilament, polypropylene mesh.
Exclusion Criteria:
-
- Have had sex in the past 5 days or had vaginal irrigation;
-
- Use oral or vaginal antibiotics, antifungal, immunosuppressant, hormone drugs or probiotics for the last 30 days.
-
- Combined with immunosuppressive diseases, diseases with contraindication of vaginal estrogen such as breast cancer, endometrial cancer.
-
- If the patient has a uterus before surgery and does not undergo total transvaginal hysterectomy during surgery,
-
- Intraoperative bladder injury or intraoperative hemorrhage >500ml or postoperative hematoma.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Peking Union Medical College Hospital
Investigators
- Principal Investigator: Lan Zhu, Peking Union Medical College
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ZS-2936